122 related articles for article (PubMed ID: 34304451)
1. [Clinical characteristics and risk factors in 118 patients with systemic lupus erythematosus and osteonecrosis].
Li NN; Chen YJ; Leng XM; Zhang W; Tian XP; Zhao Y; Zeng XF
Zhonghua Nei Ke Za Zhi; 2021 Aug; 60(8):744-750. PubMed ID: 34304451
[No Abstract] [Full Text] [Related]
2. Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study.
Long Y; Zhang S; Zhao J; You H; Zhang L; Li J; Leng X; Wang Q; Tian X; Li M; Zeng X
Lupus; 2021 Aug; 30(9):1459-1468. PubMed ID: 34082592
[TBL] [Abstract][Full Text] [Related]
3. The association of an elevated Th/Ts ratio and lupus anticoagulant with symptomatic osteonecrosis in systemic lupus erythematosus patients.
Hou R; Lei J; Xue D; Jing Y; Mi L; Guo Q; Xu K; Zhang L
Front Immunol; 2024; 15():1288234. PubMed ID: 38384449
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of incidence and clinical characteristics of osteonecrosis of femoral head in patients with systemic lupus erythematosus treated with glucocorticoid: A descriptive study based on a prospective cohort].
Xu Y; Chen S; Cai Q; Zhang C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2023 May; 37(5):605-614. PubMed ID: 37190840
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic knee osteonecrosis in patients with systemic lupus erythematosus: a case-control study.
Zhao L; Wu X; Wu H; Su J; Zhang W; Zhao Y; Zhang X; Zheng W
Rheumatol Int; 2016 Aug; 36(8):1105-11. PubMed ID: 27230994
[TBL] [Abstract][Full Text] [Related]
6. Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus.
Fialho SC; Bonfá E; Vitule LF; D'Amico E; Caparbo V; Gualandro S; Pereira RM
Lupus; 2007; 16(4):239-44. PubMed ID: 17439929
[TBL] [Abstract][Full Text] [Related]
7. Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: A retrospective case-control study.
Faezi ST; Hoseinian AS; Paragomi P; Akbarian M; Esfahanian F; Gharibdoost F; Akhlaghi M; Nadji A; Jamshidi AR; Shahram F; Nejadhosseinian M; Davatchi F
Mod Rheumatol; 2015 Jul; 25(4):590-4. PubMed ID: 25528860
[TBL] [Abstract][Full Text] [Related]
8. Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus.
Tse SM; Mok CC
Lupus; 2017 Jun; 26(7):715-722. PubMed ID: 27831540
[TBL] [Abstract][Full Text] [Related]
9. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
[TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus patients with high disease activity are associated with accelerated incidence of osteonecrosis: a systematic review and meta-analysis.
Zhang K; Zheng Y; Jia J; Ding J; Wu Z
Clin Rheumatol; 2018 Jan; 37(1):5-11. PubMed ID: 28948379
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Symptomatic Avascular Necrosis in Childhood-onset Systemic Lupus Erythematosus.
Yang Y; Kumar S; Lim LS; Silverman ED; Levy DM
J Rheumatol; 2015 Dec; 42(12):2304-9. PubMed ID: 26568601
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for avascular bone necrosis in systemic lupus erythematosus.
Mok CC; Lau CS; Wong RW
Br J Rheumatol; 1998 Aug; 37(8):895-900. PubMed ID: 9734682
[TBL] [Abstract][Full Text] [Related]
13. Osteonecrosis in systemic lupus erythematosus.
Gontero RP; Bedoya ME; Benavente E; Roverano SG; Paira SO
Reumatol Clin; 2015; 11(3):151-5. PubMed ID: 25441491
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII.
Cheng C; Huang C; Chen Z; Zhan F; Duan X; Wang Y; Zhao C; Wu Z; Xu J; Li H; Yang M; Wu R; Zhao J; Zhang S; Wang Q; Leng X; Tian X; Li M; Zeng X
Arthritis Res Ther; 2023 May; 25(1):78. PubMed ID: 37173771
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of secondary osteoporosis in systemic lupus erythematosus: prevalence and risk factors.
Gu C; Zhao R; Zhang X; Gu Z; Zhou W; Wang Y; Guo J; Bao Y; Sun C; Dong C; Gao J
Arch Osteoporos; 2019 Dec; 15(1):1. PubMed ID: 31802295
[TBL] [Abstract][Full Text] [Related]
16. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
[TBL] [Abstract][Full Text] [Related]
17. Transitional changes in the incidence of osteonecrosis in systemic lupus erythematosus patients: focus on immunosuppressant agents and glucocorticoids.
Nawata K; Nakamura J; Ikeda K; Furuta S; Nakajima H; Ohtori S; Hagiwara S; Wako Y; Miura M; Kawarai Y; Sugano M; Yoshino K; Orita S; Inage K; Akazawa T
Rheumatology (Oxford); 2018 May; 57(5):844-849. PubMed ID: 29462407
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with osteonecrosis in Thai lupus patients: a case control study.
Uea-areewongsa P; Chaiamnuay S; Narongroeknawin P; Asavatanabodee P
J Clin Rheumatol; 2009 Oct; 15(7):345-9. PubMed ID: 20009970
[TBL] [Abstract][Full Text] [Related]
19. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
[TBL] [Abstract][Full Text] [Related]
20. Development of new osteonecrosis in systemic lupus erythematosus patients in association with long-term corticosteroid therapy after disease recurrence.
Nakamura J; Ohtori S; Sakamoto M; Chuma A; Abe I; Shimizu K
Clin Exp Rheumatol; 2010; 28(1):13-8. PubMed ID: 20346232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
